SCM
KDNY
Suvretta Capital Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,748,141
| Closed | -$67.2M | – | 108 |
|
|
2023
Q2 | $67.2M | Buy |
1,748,141
+179,344
| +11% | +$6.89M | 3.59% | 8 |
|
|
2023
Q1 | $36.3M | Buy |
1,568,797
+123,967
| +9% | +$2.87M | 1.53% | 23 |
|
|
2022
Q4 | $37.9M | Buy |
1,444,830
+54,830
| +4% | +$1.44M | 1.59% | 27 |
|
|
2022
Q3 | $27.3M | Sell |
1,390,000
-394,200
| -22% | -$7.75M | 1.13% | 35 |
|
|
2022
Q2 | $31.2M | Buy |
1,784,200
+350,000
| +24% | +$6.12M | 1.19% | 34 |
|
|
2022
Q1 | $23.5M | Buy |
1,434,200
+186,732
| +15% | +$3.05M | 0.72% | 44 |
|
|
2021
Q4 | $20.3M | Buy |
1,247,468
+200,000
| +19% | +$3.26M | 0.39% | 51 |
|
|
2021
Q3 | $13.4M | Buy |
1,047,468
+79,445
| +8% | +$1.01M | 0.23% | 56 |
|
|
2021
Q2 | $13.7M | Buy |
968,023
+418,408
| +76% | +$5.91M | 0.2% | 72 |
|
|
2021
Q1 | $8.54M | Buy |
549,615
+23,160
| +4% | +$360K | 0.13% | 76 |
|
|
2020
Q4 | $8.35M | Sell |
526,455
-614,823
| -54% | -$9.75M | 0.12% | 65 |
|
|
2020
Q3 | $2.77M | Buy |
1,141,278
+338,378
| +42% | +$822K | 0.05% | 74 |
|
|
2020
Q2 | $1.86M | Buy |
+802,900
| New | +$1.86M | 0.04% | 73 |
|